AplaGen's progress is driven by a dedicated and innovative team of scientists. Our team has exceptional know-how and experience in design, synthesis and lead optimization of peptides. It has a track record of improvement and IP-generation, even for difficult areas. The expertise of our team can also be used by clients for challenging peptide projects, e.g. to identify possible 2nd generation peptides (with new IP) to existing products or products in late stage of development. Each opportunity for cooperation on such a project will be considered individually to give attention to the specific nature of the project. Our team will give you an indication of what could be done as soon as your information package will be evaluated.

An overview presentation about the principles of our innovation partnership can be found here.

 
References:

• AplaGen has optimized the sequence of a therapeutic peptide for a species-specific application in veterinary use
• AplaGen is optimizing the peptide sequence for the next generation of an established therapeutic peptide with improved binding properties (efficacy) and improved pharmacokinetic profile (stability)
• AplaGen is developing a HES attachment to a therapeutic protein as a formulation for better pharmacokinetic properties